Galvin Gaustad & Stein’s Tenaya Therapeutics TNYA Stock Holding History

Galvin Gaustad & Stein’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.64K	Hold	11,000	–	–	﹤0.01%	257
2026 Q2	$8.13K	Hold	11,000	–	–	﹤0.01%	262
2026 Q1	$7.62K	Hold	11,000	–	–	﹤0.01%	252
2025 Q4	$7.83K	Hold	11,000	–	–	﹤0.01%	250
2025 Q3	$17.8K	Hold	11,000	–	–	﹤0.01%	206
2025 Q2	$6.72K	Buy	+11,000	New	+$5.6K	﹤0.01%	191

Other funds holding TNYA

MCP

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Galvin Gaustad & Stein's TNYA Position: Q3 2026 in Review

Galvin Gaustad & Stein held its Tenaya Therapeutics (TNYA) position steady in Q3 2026 at 11,000 shares worth $6.64K. The position accounts for ﹤0.01% of the portfolio, ranked #257.

Galvin Gaustad & Stein first reported a position in TNYA in Q2 2025 and has held it in 6 quarters since. The position peaked at $17.8K in Q3 2025. 3 funds tracked by Wall St. Rank hold TNYA as of Q3 2026.

Galvin Gaustad & Stein held 11,000 shares of Tenaya Therapeutics worth $6.64K as of Q3 2026.
Galvin Gaustad & Stein left its Tenaya Therapeutics share count unchanged in Q3 2026.
Tenaya Therapeutics made up ﹤0.01% of Galvin Gaustad & Stein's portfolio in Q3 2026, its #257 holding.
Galvin Gaustad & Stein first reported a position in Tenaya Therapeutics in Q2 2025 and has held it in 6 quarters since.
Galvin Gaustad & Stein's Tenaya Therapeutics position peaked at $17.8K in Q3 2025.
3 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q3 2026, filed 8 Oct 2026.